Janssen Search
Search results
Jan Wehkamp, M.D.
JAN WEHKAMP, M.D. VICE PRESIDENT GASTROENTEROLOGY DISEASE AREA LEADER Jan Wehkamp, M.D. is Vice President, Gastroenterology Disease Area Leader for the Immunology Therapeutic Area at Janssen Research & Development, LLC. In this role, he is responsible ...
Strengthening Our Resolve to Eliminate Cancer
ASCO: The Annual Meeting that Strengthens Our Resolve to Eliminate Cancer Every year, I look forward to attending the ASCO Annual Meeting that brings together over 40,000 in the field of oncology. I cannot help but be inspired by the many people who ...
Frank de Wolf, M.D., PH.D.
As Global Head of the Janssen Prevention Center, Frank de Wolf is responsible for driving research to develop new concepts for disease prevention that will extend the healthy life span. He was appointed to this position in March 2017. Frank has been Head ...
Research & Development: Accelerating the Molecule
Development Make research reality: accelerating molecule to medicine. At Janssen, we match cutting-edge science with world-class development and commercialization to bring treatment innovation to millions of patients suffering from cardiovascular, ...
Global Reach
Article Type: Infectious Diseases & Vaccines Global Reach We seek opportunities to combine our scientific capabilities with world-class innovation from government, industry and academia to speed up the development of solutions that will combat the ...
Late Development
Late Development “Our goal is to evolve the next wave of cancer therapies into comprehensive regimens that combine several approaches tailored to patients’ individual needs.” Craig Tendler, M.D. Vice President, Late Development and Global Medical Affairs ...
Joel Greshock
JOEL GRESHOCK VICE PRESIDENT DATA SCIENCES, ONCOLOGY Joel Greshock is Vice President, Data Sciences, Oncology at Janssen Research & Development. In this position, he is responsible for creating unique and actionable medical insights using large and ...
Treatments for Neglected Tropical Diseases
Developing New Treatments for Neglected Tropical Diseases We Recognize the Urgent Need for Innovative Treatment Options In 2012, Johnson & Johnson signed the London Declaration on Neglected Tropical Diseases, a multilateral partnership to eliminate or ...
Debi Watson
DEBI WATSON VICE PRESIDENT BUSINESS DEVELOPMENT, ONCOLOGY Debi Watson is the head of the Oncology Business Development Group at Johnson & Johnson Innovation, Janssen Business Development. In this role, she leads Business Development Strategy in ...
Murray McKinnon, Ph.D.
MURRAY MCKINNON, PH.D. GLOBAL HEAD WORLD WITHOUT DISEASE ACCELERATOR As Global Head of the World Without Disease Accelerator (WWDA), Murray leads a team focused on catalyzing a paradigm shift from disease care to health care through novel approaches to ...